Učitavanje...
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
BACKGROUND: The liver is the predominant site of metastases among patients with advanced neuroendocrine tumors (NETs). Prior retrospective studies have reported high response rates in patients treated with transarterial embolization (TAE). NETs are highly vascular and are known to express vascular e...
Spremljeno u:
| Izdano u: | Ann Oncol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559904/ https://ncbi.nlm.nih.gov/pubmed/22317769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr614 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|